Crinetics Pharmaceuticals (CRNX)

• Market cap: $2.85B
• 1 day: -8.71%
• 5 days: -11.68%
• 1 month: -10.31%
• 3 months: -40.60%
• 6 months: -41.02%
• Year to date: -40.60%
• 1 year: -34.19%
• 5 years: 127.15%
• 10 years: 24.93%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

159% more call options, than puts

Call options by funds: $1.7M | Put options by funds: $654K

71% more repeat investments, than reductions

Existing positions increased: 111 | Existing positions reduced: 65

68% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 22

18% more capital invested

Capital invested by funds: $4.34B [Q3] → $5.1B (+$760M) [Q4]

17% more funds holding in top 10

Funds holding in top 10: 12 [Q3] → 14 (+2) [Q4]

5% more funds holding

Funds holding: 233 [Q3] → 244 (+11) [Q4]

1.53% more ownership

Funds ownership: 105.94% [Q3] → 107.47% (+1.53%) [Q4]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $55 80% upside
• Avg. target: $72 134% upside
• High target: $91 197% upside

4 analyst ratings

• positive: 4 100%
• neutral: 0 0%
• negative: 0 0%

Stifel Alex Thompson 57% 1-year accuracy 4 / 7 met price target	96% upside $60	Buy Initiated	25 Mar 2025
Citizens Capital Markets Jonathan Wolleben 0 / 0 met price target	197% upside $91	Market Outperform Maintained	28 Feb 2025
Jefferies Dennis Ding 0% 1-year accuracy 0 / 5 met price target	80% upside $55	Buy Upgraded	22 Jan 2025
HC Wainwright & Co. Douglas Tsao 23% 1-year accuracy 39 / 171 met price target	165% upside $81	Buy Reiterated	13 Jan 2025